AAAAAA

   
Results: 1-25 | 26-34 |
Results: 26-34/34

Authors: Boelaert, JR Taramelli, D
Citation: Jr. Boelaert et D. Taramelli, Untitled, AM J TROP M, 62(1), 2000, pp. 1-2

Authors: Boelaert, JR Sperber, K Piette, J
Citation: Jr. Boelaert et al., Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea, AIDS RES H, 15(14), 1999, pp. 1241-1247

Authors: de Monye, C Karcher, DS Boelaert, JR Gordeuk, VR
Citation: C. De Monye et al., Bone marrow macrophage iron grade and survival of HIV-seropositive patients, AIDS, 13(3), 1999, pp. 375-380

Authors: Savarino, A Pescarmona, GP Boelaert, JR
Citation: A. Savarino et al., Iron metabolism and HIV infection: Reciprocal interactions with potentially harmful consequences?, CELL BIOC F, 17(4), 1999, pp. 279-287

Authors: Saleppico, S Boelaert, JR Sale, FO Mazzolla, R Morucci, P Bistoni, F Blasi, E
Citation: S. Saleppico et al., Differential effects of iron load on basal and interferon-gamma plus lipopolysaccharide enhance anticryptococcal activity by the murine microglial cell line BV-2, J NEUROIMM, 93(1-2), 1999, pp. 102-107

Authors: Cantinieaux, B Janssens, A Boelaert, JR Lejeune, M Vermylen, C Kerrels, V Cornu, G Winand, J Fondu, P
Citation: B. Cantinieaux et al., Ferritin-associated iron induces neutrophil dysfunction in hemosiderosis, J LA CL MED, 133(4), 1999, pp. 353-361

Authors: Boelaert, JR Blasi, E
Citation: Jr. Boelaert et E. Blasi, Cryptococcosis and smoking: The potential role of iron, J INFEC DIS, 180(4), 1999, pp. 1412-1413

Authors: Simonart, T Van Vooren, JP Herbauts, J Boelaert, JR
Citation: T. Simonart et al., Nigh incidence of Kaposi's sarcoma in Iceland and the Faroe Islands, BR J CANC, 79(2), 1999, pp. 373-373

Authors: Legssyer, R Ward, RJ Crichton, RR Boelaert, JR
Citation: R. Legssyer et al., Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages, BIOCH PHARM, 57(8), 1999, pp. 907-911
Risultati: 1-25 | 26-34 |